» Articles » PMID: 24953829

Functional Consequences of Cocaine Re-exposure After Discontinuation of Cocaine Availability

Overview
Specialties Neurology
Pharmacology
Date 2014 Jun 24
PMID 24953829
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Cocaine users exhibit a wide range of behavioral impairments accompanied by brain structural, neurochemical and functional abnormalities. Metabolic mapping studies in cocaine users and animal models have shown extensive functional alterations throughout the striatum, limbic system, and cortex. Few studies, however, have evaluated the persistence of these effects following cessation of cocaine availability. The purpose of this study, therefore, was to assess the functional effects of re-exposure to cocaine in nonhuman primates after the discontinuation of cocaine self-administration for 30 or 90 days, using the quantitative autoradiographic 2-[14C]deoxyglucose (2DG) method. Rhesus monkeys self-administered cocaine (fixed interval 3-min schedule, 30 infusions per session, 0.3 mg/kg/infusion) for 100 sessions followed by 30 (n=4) or 90 days (n=3) during which experimental sessions were not conducted. Food-reinforced control animals (n=5) underwent identical schedules of reinforcement. Animals were then re-exposed to cocaine or food for one final session and the 2DG method applied immediately after session completion. Compared to controls, re-exposure to cocaine after 30 or 90 day drug-free periods resulted in lower rates of glucose utilization in ventral and dorsal striatum, prefrontal and temporal cortex, limbic system, thalamus, and midbrain. These data demonstrate that vulnerability to the effects of cocaine persists for as long as 90 days after cessation of drug use. While there was some evidence for recovery (fewer brain areas were affected by cocaine re-exposure at 90 days as compared to 30 days), this was not uniform across regions, thus suggesting that recovery occurs at different rates in different brain systems.

Citing Articles

Residual deficits in functional brain activity after chronic cocaine self-administration in rhesus monkeys.

Porrino L, Smith H, Beveridge T, Miller M, Nader S, Nader M Neuropsychopharmacology. 2021; 48(2):290-298.

PMID: 34385608 PMC: 9751134. DOI: 10.1038/s41386-021-01136-w.


The thalamus in drug addiction: from rodents to humans.

Huang A, Mitchell J, Haber S, Alia-Klein N, Goldstein R Philos Trans R Soc Lond B Biol Sci. 2018; 373(1742).

PMID: 29352027 PMC: 5790826. DOI: 10.1098/rstb.2017.0028.

References
1.
Hanlon C, Dufault D, Wesley M, Porrino L . Elevated gray and white matter densities in cocaine abstainers compared to current users. Psychopharmacology (Berl). 2011; 218(4):681-92. PMC: 3197798. DOI: 10.1007/s00213-011-2360-y. View

2.
Heil S, Johnson M, Higgins S, Bickel W . Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls. Addict Behav. 2005; 31(7):1290-4. DOI: 10.1016/j.addbeh.2005.09.005. View

3.
Mash D, Pablo J, Ouyang Q, Hearn W, Izenwasser S . Dopamine transport function is elevated in cocaine users. J Neurochem. 2002; 81(2):292-300. DOI: 10.1046/j.1471-4159.2002.00820.x. View

4.
Li X, Wolf M . Brain-derived neurotrophic factor rapidly increases AMPA receptor surface expression in rat nucleus accumbens. Eur J Neurosci. 2011; 34(2):190-8. PMC: 3936351. DOI: 10.1111/j.1460-9568.2011.07754.x. View

5.
Lim K, Choi S, Pomara N, Wolkin A, Rotrosen J . Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry. 2002; 51(11):890-5. DOI: 10.1016/s0006-3223(01)01355-5. View